Alex D'Amico

Principal accouting officer, Synvista Therapeutics, Inc.

Companies

CytosorbentsChief financial officer Aug 15, 2023 to Aug 15, 2023¹
Trulieve Cannabis Corp.Chief financial officer Feb 4, 2021 to Jan 3, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cytosorbents CTSO210,000 shares³$1.0M at $4.98Aug 15, 2023
Trulieve Cannabis Corp. TRLV82,869 shares⁴$852.3K at $10.29Dec 29, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 29, 2022Shares withheld for tax 2,718 shares at $7.74 of Trulieve Cannabis Corp.⁴
May 24, 2022Bought 1,500 shares at $14.39 of Trulieve Cannabis Corp.⁵
Feb 24, 2022Granted 20,135 shares of Trulieve Cannabis Corp.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCytosorbents, Chief financial officer
2
SEC EDGARTrulieve Cannabis Corp., Chief financial officer
3
SEC EDGARCytosorbents shares after the filing of Aug 15, 2023
4
SEC EDGARTrulieve Cannabis Corp. shares after the filing of Dec 29, 2022
5
SEC EDGARForm 4 filed May 25, 2022
6
SEC EDGARForm 4 filed Feb 28, 2022